Examining Hepatitis C Virus Treatment Access
A Review of Select State Medicaid Fee-For-Service and Managed Care Programs
Related Articles
-
Article 2015 | Recommendations for Management of Hep C among People Who Inject Drugs
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections occur among people who inject drugs (PWID). In many low and middle income countries large HCV epidemics have also emerged among PWID populations.
-
NYS Senate Act: Requiring hospitals to offer hepatitis C testing
There is an Act in the Health Committee of the NYS Senate which would require hospitals to offer the hep C Test to Baby Boomers
-
O’Neill Institute Launches Hep C Policy Project
The O’Neill Institute for National and Global Health Law, a part of the Georgetown Law, announces the launch of the Hepatitis Policy Project (HPP) to focus on issues and barriers of access to effective treatments for hepatitis C.
-
2019 Hep Free NYC Awareness Event on the Steps of City Hall
May Hepatitis Awareness Month, National Hepatitis Testing Day and Hispanic Hepatitis Awareness Day.
-
NYC Health Dept Hep B & C Annual Report of Activities (2015)
This report presents an overview of the New York City Health Department’s 2015 surveillance and research data on hepatitis B and C in NYC, as well as the Health Department’s programmatic activities to address these epidemics.
-
Preventing, Identifying and Managing Hepatitis B Virus Infection: City Health Information (NYC Health Dept, 2018)
The NYC Health Department recently released the 2018 version of City Health Information (CHI): Preventing, Identifying, and Managing Hepatitis B Virus Infection.
-
Drug User Health Capacity Building Initiative (NYS DOH)
AIDS Institute Drug User Health Capacity Building Initiative in January 2020. All Article 28 facilities are eligible to apply. Applications are due December 18, 2019. For more information, agencies can call 518-474-3045. Completed applications can be submitted to Rob Curry at R...
-
Comment! HBV Screening: USPSTF Recommendation Statement
It is estimated that about 700,000 to 1.4 million persons in the United States have chronic HBV infection ( 1, 2). In the United States, persons considered at high risk for HBV infection include persons from high-prevalence countries, persons who...
